Invo Bioscience Inc Reports Results For The Quarter Ended In September: Earnings Summary

INVO Fertility

14/11/2022 22:02

* INVO Bioscience Inc  INVO.OQ  reported a quarterly
adjusted loss
of 21 cents​​ per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue rose 7.8% to $235.00 thousand from a year ago;
analysts
expected $500.00 thousand. 
    * INVO Bioscience Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * INVO Bioscience Inc shares had risen by 6.6% this
quarter and
lost 66.1% so far this year.
    * The company reported a quarterly loss of $2.55 million.
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.13          -0.21          Missed
 Jun. 30 2022      -0.24          -0.23          Beat
 Mar. 31 2022      -0.25          -0.22          Beat
 Dec. 31 2021      -0.22          -0.01          Beat